Friday, 16 October 2026European Markets

JDE PEET'S And HEINEKEN HOLDING Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(VIANEWS) - JDE PEET'S (JDEP.AS) is among this list of stock assets with the highest dividend rate and return on equity on the Consumer Defensive sector.

Financial Asset Price Forward Dividend Yield Return on Equity
JDE PEET'S (JDEP.AS) €26.92 2.56% 6.83%
HEINEKEN HOLDING (HEIO.AS) €78.90 2.11% 14.6%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. JDE PEET'S (JDEP.AS)

2.56% Forward Dividend Yield and 6.83% Return On Equity

JDE Peet's N.V., together with its subsidiaries, provides various coffee and tea products worldwide. It operates through CPG Europe, CPG LARMEA, CPG APAC, Out-of-Home, and Peet's segments. The company sells its products under the L'OR, Peet's, Jacobs, Senseo, Tassimo, Douwe Egberts, OldTown, Super, Pickwick, and Moccona brand names. It serves various businesses, such as offices, hotels, bars, and restaurants, as well as coffee stores. JDE Peet's N.V. was founded in 1753 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, JDE PEET'S has a trailing twelve months EPS of €1.55.

PE Ratio

JDE PEET'S has a trailing twelve months price to earnings ratio of 17.37. Meaning, the purchaser of the share is investing €17.37 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.83%.

More news about JDE PEET'S.

2. HEINEKEN HOLDING (HEIO.AS)

2.11% Forward Dividend Yield and 14.6% Return On Equity

Heineken Holding N.V., through its subsidiaries, engages in brewing and selling beer and cider in the Netherlands and internationally. The company's portfolio consists of approximately 300 international, regional, local, and specialty beers and ciders. The company was founded in 1864 and is based in Amsterdam, the Netherlands. Heineken Holding N.V. is a subsidiary of L'Arche Green N.V.

Earnings Per Share

As for profitability, HEINEKEN HOLDING has a trailing twelve months EPS of €4.67.

PE Ratio

HEINEKEN HOLDING has a trailing twelve months price to earnings ratio of 16.9. Meaning, the purchaser of the share is investing €16.9 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.6%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 27.7%, now sitting on 28.72B for the twelve trailing months.

Moving Average

HEINEKEN HOLDING's value is above its 50-day moving average of €75.38 and above its 200-day moving average of €72.78.

More news about HEINEKEN HOLDING.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com